Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare And The Letter “S”: How Restricted Will Formularies Be?

Executive Summary

The formulary procedures under the Medicare prescription drug legislation may essentially limit discounting to therapeutic classes with three or more competitors

You may also be interested in...



Formulary Balancing Act: Medicare Rules Weigh Access Versus Cost Control

The Medicare prescription drug benefit implementing regulations would require formularies to contain at least two drugs in every therapeutic class

Formulary Balancing Act: Medicare Rules Weigh Access Versus Cost Control

The Medicare prescription drug benefit implementing regulations would require formularies to contain at least two drugs in every therapeutic class

Medicare Formularies Will Have Two Drugs Per Class; CMS To Track Atypicals

Medicare prescription drug plan formularies will have at least two drugs in each class, CMS Administrator-designate Mark McClellan says

Related Content

UsernamePublicRestriction

Register

ID1132956

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel